Pfizer offshoot Zoetis enjoys stock surge after IPO

Stock for Pfizer's ($PFE) animal health spinoff Zoetis ($ZTS) soared 21% after raising more than $2.2 billion in its initial public offering. Shares went for $31 apiece this morning after selling for $26 each yesterday, above Pfizer's proposed offering range of $22 to $25. The biggest IPO since Facebook, Pfizer offered up about 17% of Zoetis. Yesterday, Zoetis sold 86.1 million shares, according to Bloomberg. Story